Dare Bioscience, Inc. (DARE): Total Assets
$32.47M
As of 2025-12-31
$22.37M
As of 2026-06-30
-9.5%
3-year compound annual growth
+33.9%
5-year compound annual growth
-8.4%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $32.47M | +46.9% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $22.10M | +3.8% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $21.28M | -51.4% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $43.83M | -21.5% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $55.81M | +639.1% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $7.55M | +1.5% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $7.44M | -4.9% | 2021-03-30, Balance as of period end |
| 2018-12-31 | $7.83M | -45.1% | 2020-03-27, Balance as of period end |
| 2017-12-31 | $14.26M | n/m | 2019-04-01, Balance as of period end |
| 2016-12-31 | $44.6K | -99.9% | 2018-03-28, Balance as of period end |
| 2015-12-31 | $78.22M | +46.5% | 2017-06-13, Balance as of period end |
| 2014-12-31 | $53.39M | +682.1% | 2016-03-10, Balance as of period end |
| 2013-12-31 | $6.83M | n/a | 2015-03-19, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $32.47M | +46.9% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $5.37M | -6.8% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $91.03M | 0.0% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $359.1K | +1.3% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $34.75M | +60.4% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $114.11M | +17.8% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $28.71M | +0.4% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $10.26M | -59.9% |
| Rallybio Corp (RLYB) | 2025-12-31 | $62.26M | -8.6% |
Compare DARE, SXTP, STTK, BSPK side by side · Screen every company in Pharmaceutical Preparations ↗